Concord Wealth Partners Sells 7,170 Shares of Aflac Incorporated (NYSE:AFL)

Concord Wealth Partners reduced its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 62.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,306 shares of the financial services provider's stock after selling 7,170 shares during the period. Concord Wealth Partners' holdings in Aflac were worth $481,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Secure Asset Management LLC lifted its position in shares of Aflac by 1.0% during the 3rd quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider's stock valued at $1,094,000 after acquiring an additional 96 shares during the last quarter. Ascent Group LLC lifted its holdings in shares of Aflac by 0.6% during the second quarter. Ascent Group LLC now owns 17,231 shares of the financial services provider's stock valued at $1,539,000 after purchasing an additional 99 shares during the last quarter. Ieq Capital LLC boosted its position in shares of Aflac by 0.5% in the 2nd quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider's stock valued at $1,945,000 after purchasing an additional 101 shares during the period. New Century Financial Group LLC increased its stake in Aflac by 2.5% in the 3rd quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider's stock worth $469,000 after purchasing an additional 101 shares in the last quarter. Finally, Forum Financial Management LP raised its holdings in Aflac by 1.3% during the 2nd quarter. Forum Financial Management LP now owns 8,337 shares of the financial services provider's stock worth $745,000 after buying an additional 107 shares during the period. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Stock Up 0.0 %

AFL stock traded up $0.05 during trading hours on Monday, hitting $109.80. The company's stock had a trading volume of 2,162,710 shares, compared to its average volume of 2,219,270. The company has a market capitalization of $62.39 billion, a PE ratio of 12.12, a price-to-earnings-growth ratio of 2.62 and a beta of 0.95. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50. The stock has a 50 day moving average price of $110.32 and a two-hundred day moving average price of $96.95.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, topping analysts' consensus estimates of $1.60 by $0.23. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The firm's revenue for the quarter was down .7% on a year-over-year basis. During the same period in the previous year, the company posted $1.58 earnings per share. On average, equities research analysts expect that Aflac Incorporated will post 6.76 earnings per share for the current year.

Aflac Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date was Wednesday, August 21st. Aflac's dividend payout ratio (DPR) is currently 22.08%.

Insider Activity at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of Aflac stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the sale, the director now owns 18,158 shares of the company's stock, valued at approximately $1,796,552.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.90% of the company's stock.

Analyst Ratings Changes

Several brokerages have commented on AFL. Bank of America raised their target price on shares of Aflac from $115.00 to $124.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. Citigroup lifted their price objective on shares of Aflac from $84.00 to $93.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 23rd. JPMorgan Chase & Co. boosted their target price on shares of Aflac from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Thursday, October 3rd. Morgan Stanley raised their target price on Aflac from $91.00 to $98.00 and gave the stock an "equal weight" rating in a research report on Monday, August 19th. Finally, Wells Fargo & Company lifted their price target on Aflac from $90.00 to $106.00 and gave the company an "equal weight" rating in a report on Thursday, October 10th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Aflac has a consensus rating of "Hold" and an average target price of $97.53.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.